Unlike EGFR mutation, which is increased in never smokers, KRAS mutation in NSCLC has an odd decrease among never smokers (29), and it is typically found in tumors from patients who smoke (often heavy smokers) (18). This evidence concerns the gene EGFR and non-small cell lung carcinoma.